View Author
cancer patient breast tumor marker tissue breast cancer prostate level prostate cancer study disease assay protein therapy expression prognostic treatment biomarker inhibitor carcinoma serum tumour value chemotherapy screening concentration plasminogen survival prognosis colorectal cancer methylation activator colorectal oncol analysis detection stage factor recommendation panel sample antigen diagnosis response trial urokinase-type plasminogen activator outcome testicular tumor markers group table result adjuvant receptor pai ‑1 evidence guideline method measurement recurrence monitoring antibody variant metastatic chemistry lymph review tissue inhibitor women breast cancer patients prognostic value germ cell tumors prostate-specific antigen testicular cancer metalloproteinase evaluation urokinase-type report timp 1-v
8 Most Recent Publications
|
Clinical utility of level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1
(Article)
Schmitt, M. Mengele, K. Napieralski, R. Magdolen, V. Reuning, U. Gkazepis, A. Sweep, F.C. Brünner, N. Foekens, J.A. Harbeck, N. |
2010-11-01
|
|
Methylated genes as new cancer biomarkers
(Article)
Duffy, M.J. Napieralski, R. Martens, J.W.M. Span, P.N. Spyratos, F. Sweep, F.C. Brünner, N. Foekens, J.A. Schmitt, M. |
2009-02-01
|
|
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
(Article)
Sturgeon, C.M. Duffy, M.J. Haglund, C. Harbeck, N. Hayes, D.F. Holten-Andersen, M. Klee, G.G. Lamerz, R. Looijenga, L.H.J. Molina, R. Nielsen, H.J. Rittenhouse, H. Stenman, U-H. Semjonow, A. Shih, I-M. Sibley, P. Söleformos, G. Stephan, C. Sokoll, L. Hoffman, B.R. Diamandis, E.P. Lilja, H. Brünner, N. Chan, D.W. Babaian, R. Bast Jr, R.C. Dowell, B. Esteva, F.J |
2008-12-01
|
|
The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: An immunohistochemical study
(Article)
Golouh, R. Cufer, T. Foekens, J.A. Martens, J.W.M. Sadikov, A. Nussdorfer, P. Usher, P.A. Brünner, N. Schmitt, M. Lesche, R. Maier, S. Timmermans, A.M. |
2008-07-01
|
|
Biomarkers for therapeutic efficacy
(Article)
Brünner, N. Vang Nielsen, K. Offenberg, H. Sweep, F.C. Martens, J.W.M. Foekens, J.A. Folprecht, G. Lutz, M.P. Mechetner, E. |
2007-09-01
|
|
Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue
(Article)
Usher, P.A. Sieuwerts, A.M. Bartels, A. Lademann, U. Nielsen, H.J. Holten-Andersen, L. Foekens, J.A. Brünner, N. Offenberg, H. |
2007-09-01
|
|
Concentrations of TIMP1 mRNA splice variants and TIMP-1 protein are differentially associated with prognosis in primary breast cancer
(Article)
Sieuwerts, A.M. Usher, P.A. Meijer van Gelder, M.E. Timmermans, A.M. Martens, J.W.M. Brünner, N. Klijn, J.G.M. Offenberg, H. Foekens, J.A. |
2007-07-01
|
|
European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group standard operating procedure for the preparation of human tumour tissue extracts suited for the quantitative analysis of tissue-associated biomarkers
(Article)
Schmitt, M. Mengele, K. Schueren, E. Sweep, F.C. Foekens, J.A. Brünner, N. Laabs, J. Malik, A. Harbeck, N. |
2007-03-01
|
